Effects of dexmedetomidine and propofol on lower esophageal sphincter and gastroesophageal pressure gradient in healthy volunteers

Anesthesiology

Volumn 112, Issue 1, 2010, Pages 19-24

  Turan, Alparslan ^a   Wo, John ^b   Kasuya, Yusuke ^b,f   Govinda, Raghavendra ^c,g   Akça, Ozan ^d   Dalton, Jarrod E ^e   Sessler, Daniel I ^a   Rauch, Stefan ^d  

^a Department of Outcomes Research ^*  (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c University of Louisville School of Medicine   (United States)

^d Outcomes Research Consortium   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^g TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; PROPOFOL; HYPNOTIC SEDATIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG BLOOD LEVEL; ESOPHAGUS PRESSURE; EXPIRED AIR; FEMALE; HUMAN; HUMAN EXPERIMENT; INHALATION; LOWER ESOPHAGUS SPHINCTER; MALE; MEDICAL RECORD; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESOPHAGUS; MANOMETRY; PHYSIOLOGY; PRESSURE; STOMACH;

ADOLESCENT; ADULT; CROSS-OVER STUDIES; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ESOPHAGEAL SPHINCTER, LOWER; ESOPHAGUS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MANOMETRY; PRESSURE; PROPOFOL; STOMACH; YOUNG ADULT;

EID: 74049149900     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/01.anes.0000365963.97138.54     Document Type: Article

References (35)

1. Richter JE: Gastrooesophageal reflux disease. Best Pract Res Clin Gastroenterol 2007; 21:609-631
2. Smith G, Dalling R, Dougan LR, Williams TI: The effect of thiopentone and suxamethonium on gastrooesophageal pressure gradients. Br J Anaesth 1978; 50:76-77
3. Cotton BR, Smith G: The lower oesophageal sphincter and anaesthesia. Br J Anaesth 1984; 56:37-46
4. Ahtaridis G, Snape WJ Jr, Cohen S: Lower esophageal sphincter pressure as an index of gastroesophageal acid reflux. Dig Dis Sci 1981; 26:993-998
5. Haddad JK: Relation of gastroesophageal reflux to yield sphincter pressures. Gastroenterology 1970; 58:175-184
6. Seeff LC, Richards TB, Shapiro JA, Nadel MR, Manninen DL, Given LS, Dong FB, Winges LD, McKenna MT: How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology 2004; 127:1670-1677
7. Fujii Y, Hoshi T, Takahashi S, Toyooka H: Propofol decreases diaphragmatic contractility in dogs. Anesth Analg 1999; 89:1557-1560
8. Kovac JR, Preiksaitis HG, Sims SM: Functional and molecular analysis of L-type calcium channels in human esophagus and lower esophageal sphincter smooth muscle. Am J Physiol Gastrointest Liver Physiol 2005; 289:998-1006
9. Bagcivan I, Gursoy S, Yildirim MK, Kaya Temiz T, Yildirim S, Yilmaz A, Turan M: Investigation of relaxant effects of propofol on sheep sphincter of Oddi. Pancreatology 2007; 7:174-179
10. Thorn K, Thorn SE, Wattwil M: The effects of cricoid pressure, remifentanil, and propofol on esophageal motil-ity and the lower esophageal sphincter. Anesth Analg 2005; 100:1200-1203
11. Ahlstrand R, Leon A, Thörn SE, Wattwil M: Effects of propofol on esophageal sphincters, measured with solid-state high-resolution manometry (abstract). ANESTHESIOLOGY 2008; 109:A1135
12. McIntyre AS, Thompson DG, Burnham WR, Walker E: The effect of alpha-1-adrenoreceptor agonist and antagonist administration on human upper gastrointestinal transit and motility. Aliment Pharmacol Ther 1992; 6:415-426
13. Blandizzi C: Enteric alpha-2 adrenoceptors: Pathophysio-logical implications in functional and inflammatory bowel disorders. Neurochem Int 2007; 51:282-288
14. Sidhu AS, Triadafilopoulos G: Neuro-regulation of lower esophageal sphincter function as treatment for gastro-esophageal reflux disease. World J Gastroenterol 2008; 14:985-990
15. Bruck H, Gossl M, Spitthover R, Schäfers RF, Kohnle M, Philipp T, Wenzel RR: The nitric oxide synthase inhibitor L-NMMA potentiates noradrenaline-induced vasoconstric-tion: Effects of the alpha2-receptor antagonist yohimbine. J Hypertens 2001; 19:907-911
16. Snapir A, Talke P, Posti J, Huiku M, Kentala E, Scheinin M: Effects of nitric oxide synthase inhibition on dexmedeto-midine-induced vasoconstriction in healthy human volunteers. Br J Anaesth 2009; 102:38-46
17. Shirasaka T, Qiu DL, Kannan H, Takasaki M: The effects of centrally administered dexmedetomidine on cardiovascular and sympathetic function in conscious rats. Anesth Analg 2007; 105:1722-1728
18. Goyal RK, Chaudhury A: Physiology of normal esophageal motility. J Clin Gastroenterol 2008; 42:610-619
19. Schnider TW, Minto CF, Gambus PL, Andresen C, Goodale DB, Shafer SL, Youngs EJ: The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. ANESTHESIOLOGY 1998; 88: 1170-1182
20. Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, Schwam EM, Siegel JL: Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: Study with intravenous midazolam. J Clin Psychopharma-cology 1990; 10:244-251
21. Mittal RK, Rochester DF, McCallum RW: Electrical and mechanical activity in the human lower esophageal sphincter during diaphragmatic contraction. J Clin Invest 1988; 81:1182-1189
22. Fung KP, Math MV, Ho CO, Yap KM: Midazolam as a sedative in esophageal manometry: A study of the effect on esophageal motility. J Pediatr Gastroenterol Nutr 1992; 15:85-88
23. Marsh JK, Hoffman SM, Dmuchowski CF: Effect of intravenous midazolam on esophageal motility testing in normal human volunteers. Am J Gastroenterol 1993; 88:860-863
24. Hall A, Moossa A, Clark J, Cooley G, Skinner D: The effects of premedication drugs on the lower oesophageal high pressure zone and reflux status of Rhesus monkeys and man. Gut 1975; 16:347-352
25. Weihrauch T, Forster C, Kohler H, Ewe K, Krieglstein J: Effect of intravenous diazepam on human lower oesopha-geal sphincter pressure under controlled double blind crossover conditions. Gut 1979; 20:64-67
26. Hey VM, Ostick DG, Mazumder JK, Lord WD: Pethidine, metoclopramide and the gastro-oesophageal sphincter: A study in healthy volunteers. Anaesthesia 1981; 36:173-176
27. Dowlatashi K, Evander A, Walther B, Skinner DB: Influence of morphine on the distal oesophagus and the lower oesophageal sphincter: A manometric study. Gut 1985; 26:802-806
28. Rosa G, Conti G, Orsi P, D'Alessandro F, La Rosa I, Di Giuqno G, Gasparetto A: Effects of low-dose propofol administration on central respiratory drive, gas exchanges and respiratory pattern. Acta Anaesthesiol Scand 1992; 36:128-131
29. Blouin RT, Seifert HA, Babenco HD, Conard PF, Gross JB: Propofol depresses the hypoxic ventilatory response during conscious sedation and isohypercapnia. ANESTHESIOLOGY 1993; 79:1177-1182
30. Carollo DS, Nossaman BD, Ramadhyani U: Dexmedetomi-dine: A review of clinical applications. Curr Opin Anaes-thesiol 2008; 21:457-461
31. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD: The effects of increasing plasma concentrations of dexmedeto-midine in humans. Anesth Analg 2005; 100:1200-1203
32. Doufas AG, Bakhshandeh M, Bjorksten AR, Greif R, Sessler DI: Automated responsiveness test (ART) predicts loss of consciousness and adverse physiologic responses during propofol conscious sedation. ANESTHESIOLOGY 2001; 94:585-592
33. Doufas AG, Bakhshandeh M, Bjorksten AR, Shafer SL, Sessler DI: Induction speed is not a determinant of propo-fol pharmacodynamics. ANESTHESIOLOGY 2004; 101:1112-1121
34. Doufas AG, Bakhshandeh M, Haugh GS, Bjorksten AR, Greif R, Sessler DI: Automated responsiveness test and bispectral index monitoring during propofol and propo-fol/N2O sedation. Acta Anaesthesiol Scand 2003; 47:951-957
35. Venn RM, Grounds RM: Comparison between dexmedeto-midine and propofol for sedation in the intensive care unit: Patient and clinician perceptions. Br J Anaesth 2001; 87:684-690